Our work proposes SLC16A13 gain-of-function genetic variants to increase T2D risk and raises the question about a potential causative role for SLC16A13 other than SLC16A11, highlighting the need of additional studies to better understand the distinct mechanism through which these SLC16 transporters affect the development of T2D. Here, SLC16A11 is linked to type 2 diabetes mellitus.